TISSUE REPAIR RESEARCH
TB-500 Australia
A synthetic fragment of Thymosin Beta-4, supplied lyophilised in 10mg vials with independent batch analysis and domestic Australian dispatch.
What TB-500 is
TB-500 is a synthetic peptide corresponding to an active region of Thymosin Beta-4, a naturally occurring protein involved in actin binding. Because the full protein is large and difficult to work with, researchers commonly use this shorter fragment as a tractable substitute in cell and animal model work.
It is worth noting that TB-500 appears on the World Anti-Doping Agency prohibited list, so researchers working with athlete populations or in sports science contexts should be aware of that status. It is not an approved medicine in Australia.
Catalogue Specifications
Presentation
Lyophilised powder in a sealed 10mg vial. Also available in a combination vial with BPC-157, and as a component of the KLOW multi-peptide blend.
Verification
Independent HPLC analysis on every lot prior to release, with the certificate tied to the batch number on the vial and supplied on request.
Handling
Keep sealed vials frozen and protected from light. Reconstitute with bacteriostatic water and refrigerate the working solution between two and eight degrees Celsius.
Browse the tissue repair catalogue
Research Use Only. Not registered on the Australian Register of Therapeutic Goods. Not a medicine and not supplied for human or veterinary use. Nothing on this page is medical advice or a therapeutic claim. Purchasers must be 18 years or older and qualified to handle research chemicals.